Pharma

ASL Pharma Launches New Brand and KL HQ to Anchor Regional Expansion

ASL Pharma unveiled its new brand identity and headquarters in Kuala Lumpur, marking its evolution into a structured, quality-focused compounding…

1 month ago

China’s Biotech Sector Emerges as Bright Spot Amid Economic Rebalancing

China’s biotech and specialty pharma sectors are regaining momentum as policy risks ease and global demand drives earnings recovery.

3 months ago

Pharm-D Health Science’s Lang Bragman Clinches Malaysia Book of Records for Largest Probiotics Range

Built on a foundation of science, safety, and innovation, Lang Bragman’s products utilise science-backed and patented probiotic strains, and are…

4 months ago

Malaysia Showcases Regional Leadership at 2nd Pharma & Healthcare Business Expo 2025

Malaysia positions itself as ASEAN’s healthcare hub as industry leaders convene at the 2nd Pharma & Healthcare Business Expo 2025.

6 months ago

Pharmaniaga Eyes Biopharma Expansion, Logistics Growth After Regularisation Plan

Pharmaniaga completes regularisation, boosts logistics capacity, and eyes biopharma growth with halal-certified insulin as a potential key revenue driver.

7 months ago

Palm Oil Tocotrienols: Natural Support for Beauty and Healthy Aging

One natural compound that has gained increasing attention in dermatology is tocotrienols, a lesser-known form of vitamin E. Unlike the…

7 months ago

Novo Nordisk to Cut 9,000 Jobs in Major Restructuring Amid Growing Competition

Novo Nordisk plans to cut 9,000 jobs to save costs and streamline operations amid increasing competition and slowing sales for…

7 months ago

Malaysia to Host 2nd Pharma and Healthcare Expo 2025 in October

Malaysia will host the 2nd Malaysia Pharma and Healthcare Expo 2025 from 7–9 October, featuring global healthcare stakeholders and over…

9 months ago

Palmitic Acid in Your Diet – Separating Cancer Fear from Fact

Palmitic acid is the most abundant saturated fatty acid in the human body, making up approximately 20-30% of all fatty…

1 year ago

Duopharma Biotech records strong growth in Q3 FY2024

Duopharma Biotech reports 15.4% revenue growth in Q3 FY2024, driven by strong public health sales and new government supply contracts.

1 year ago

This website uses cookies.